Related Experiment Video
Updated: Jul 18, 2026
14:56
Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
Is Israel ready for disease management?
1Linden Consulting Group, Portland, OR, USA. ariellinden@yahoo.com
The Israel Medical Association Journal : IMAJ
|November 28, 2006
Summary
Chronic diseases cause 60% of global deaths, often from modifiable behaviors. This paper proposes integrating disease management (DM) strategies into Israel's healthcare system to reduce morbidity and healthcare utilization.
Area of Science:
- Public Health
- Healthcare Management
- Chronic Disease Epidemiology
Background:
- Chronic diseases account for approximately 60% of all global deaths, largely driven by modifiable health behaviors.
- Disease management (DM) programs in the United States aim to reduce healthcare utilization and morbidity in chronically ill patients by supplementing episodic medical care.
- The U.S. and Israel share similar demographic profiles within their chronically ill populations.
Purpose of the Study:
- To provide a conceptual framework for integrating disease management (DM) into Israel's existing healthcare system.
- To assess the suitability of Israel's healthcare infrastructure for population-wide DM implementation.
- To support decision-making for stakeholders considering investment in DM strategies in Israel.
Main Methods:
- Conceptual analysis of disease management principles.
- Examination of the Israeli healthcare system's organizational structure.
- Comparative analysis of U.S. and Israeli healthcare demographics for chronic illness.
Main Results:
- The Israeli healthcare system's structure is uniquely conducive to implementing DM on a population-wide scale.
- Integrating DM strategies can potentially reduce morbidity and healthcare services utilization among chronically ill individuals in Israel.
- A clear framework is presented for how DM can be incorporated.
Conclusions:
- Israel has a significant opportunity to adopt and adapt U.S.-based disease management strategies.
- Implementing DM could lead to improved health outcomes and more efficient healthcare delivery for chronic conditions in Israel.
- Stakeholder decisions are crucial for the successful adoption and investment in population-wide DM programs.
Related Concept Videos
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
01:28Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:20Infection
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...